Office of the Director, National Institutes of Health; Notice of Meeting, 63917-63918 [07-5616]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 218 / Tuesday, November 13, 2007 / Notices
Special Emphasis Panel Institutional
Research Training Grant (T32) applications.
Date: December 3, 2007.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, 5B01, Rockville, MD
20852. (Telephone Conference Call.)
Contact Person: Anne Krey, Scientific
Review Administrator, Division of Scientific
Review, National Institute of Child Health
and Human Development, National Institutes
of Health, Bethesda, MD 20892, 301–435–
6908.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 2, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5618 Filed 11–09–07; 8:45 am]
of Health, Bethesda, MD 20892, 301–435–
6908.
(Catalogue of federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 2, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5619 Filed 11–09–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
rfrederick on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel Special Emphasis
Panel Review—Shultz P01.
Date: December 7, 2007.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, 5B01, Rockville, MD
20852. (Telephone Conference Call.)
Contact Person: Anne Krey, Scientific
review Administrator, Division of Scientific
review, National Institute of Child Health,
and Human Development, National Institutes
VerDate Aug<31>2005
16:59 Nov 09, 2007
Jkt 214001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Phenome Project.
Date: November 30, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference
Call).
Contact Person: Ellen S. Buczko, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2676,
ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
63917
Dated: November 2, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5622 Filed 11–9–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: December 3–5, 2007.
Time: December 3, 2007, 8 a.m. to 1 p.m.
Agenda: The Recombinant DNA Advisory
Committee will review and discuss selected
human gene transfer protocols as well as
related data management activities. There
will also be follow-ups on Consideration of
a Proposed Major Action under section III–
A–1 of the NIH Guidelines for Research
Involving Recombinant DNA Molecules and
on a serious adverse event on a gene transfer
trial using an AAV vector.
Place: National Institutes of Health,
Building 31, Floor 6C, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Time: December 4, 2007, 8 a.m. to 3 p.m.
Agenda: Continued.
Place: National Institutes of Health,
Building 31, Floor 6C, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Time: December 5, 2007, 8 a.m. to 10:30
a.m.
Agenda: Continued.
Place: National Institutes of Health,
Building 31, Floor 6C, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory
Committee Coordinator, Office of
Biotechnology Activities, National Institutes
of Health, 6705 Rockledge Drive, Room 750,
Bethesda, MD 20892–7985, 301–496–9838,
lewallla@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
E:\FR\FM\13NON1.SGM
13NON1
63918
Federal Register / Vol. 72, No. 218 / Tuesday, November 13, 2007 / Notices
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www4.od.nih.gov/oba/, where an agenda and
any additional information for the meeting
will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance Program
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the
official government programs contained in
the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the
number and title of affected individual
programs for the guidance of the public.
Because the guidance in this notice covers
virtually every NIH and Federal research
program in which DNA recombinant
molecule techniques could be used, it has
been determined not to be cost effective or
in the public interest to list these programs.
Such a list would likely require several
additional pages. In addition, NIH could not
be certain that every Federal program would
be included as many Federal agencies, as
well as private organizations, both national
and international, have elected to follow the
NIH Guidelines. In lieu of the individual
program listing, NIH invites readers to direct
questions to the information address above
about whether individual programs listed in
the Catalog of Federal Domestic Assistance
are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 2, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5616 Filed 11–9–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
rfrederick on PROD1PC67 with NOTICES
Notice Announcing Public Workshop
Privacy Office, Department of
Homeland Security (DHS).
ACTION: Notice Announcing Public
Workshop.
AGENCY:
SUMMARY: The Department of Homeland
Security Privacy Office will host a
VerDate Aug<31>2005
15:30 Nov 09, 2007
Jkt 214001
public workshop, CCTV: Developing
Privacy Best Practices.
DATES: The two-day workshop will be
held on December 17, 2007, from 8:30
a.m. to 5 p.m. and on December 18,
2007, from 8:30 a.m. to 12:30 p.m.
ADDRESSES: The workshop will be held
in the Gallery Ballroom at the Hilton
Arlington Hotel, Arlington, VA (Ballston
Metro).
FOR FURTHER INFORMATION CONTACT:
Toby Milgrom Levin, DHS Privacy
Office, Department of Homeland
Security, Washington, DC 20528; by
telephone 703–235–0780; by facsimile
703-235–0790; or by e-mail at
privacyworkshop@dhs.gov.
SUPPLEMENTARY INFORMATION: The
Department of Homeland Security
(DHS) Privacy Office is holding a public
workshop to bring together leading
government, academic, policy, and
international experts to discuss the
impact on privacy and civil liberties of
closed circuit television (CCTV). This
workshop will provide a forum to begin
a discussion to inform development of
best practices for the use of CCTV by
government agencies. This public
workshop is particularly timely given
that government agencies at all levels
are expressing interest in the use of
CCTV, and DHS has awarded a number
of grants that have been used to
facilitate its use. The workshop will
explore how CCTV technology can be
used in a manner that respects the
privacy and civil liberties of the
American public. Development of best
practices for the use of this technology
will aid in building public trust that
privacy and civil liberties will be
considered when making decisions to
use CCTV. The two-day workshop will
consist of a series of panel discussions
exploring a variety of perspectives
regarding the use of CCTV, including
technology, law enforcement,
community, international, and legal and
policy perspectives. The workshop will
culminate in a panel discussion on best
practices for CCTV, during which
panelists will share their various
perspectives and individual
recommendations. Workshop attendees
will have an opportunity to ask
questions after each panel.
The workshop is open to the public,
and no fee is required for attendance.
Topics for Comment: To develop a
comprehensive record regarding best
practices for CCTV, the DHS Privacy
Office also invites interested parties to
submit written comments as described
below. Comments should be received on
or before Friday, November 30, 2007,
and should be as specific as possible.
The Privacy Office is particularly
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
interested in receiving comments on the
following topics:
1. Are there existing state, local, or
international programs that have
developed privacy and civil liberties
guidelines for CCTV that can serve as
resources for the development of best
practices?
2. How can CCTV systems be
designed in a manner that respects
privacy and civil liberties?
3. What measures are necessary to
protect privacy and civil liberties when
governments have the ability to link into
privately owned CCTV networks or have
access to images and footage that such
networks have captured?
4. How can Privacy Impact
Assessments (PIAs) be used as a means
of protecting privacy in this area? What
would make for an effective PIA? How
can government agencies incorporate
the findings of PIAs into their CCTV
networks and guidelines?
5. What are the privacy and civil
liberties best practices you would
recommend for government use of
CCTV?
All submissions received must
include the docket number: DHS–2007–
0076. Written comments may be
submitted by any one of the following
methods:
• E-mail: privacyworkshop@dhs.gov.
Include ‘‘CCTV Workshop Comment’’ in
the subject line of the message.
• Facsimile: 703–235–0442.
• Mail: Toby Milgrom Levin,
Department of Homeland Security,
Washington, DC 20528.
All written comments received will be
posted without alteration on the
https://www.dhs.gov/privacy Web page
for this workshop, including any
personal contact information provided.
Registration: In order to assist us in
planning for the workshop, we ask that
attendees register in advance. To
register, please send an e-mail to
privacyworkshop@dhs.gov with ‘‘CCTV
Workshop Registration’’ in the subject
line, and your name and organizational
affiliation, if any, in the body of the
e-mail. Alternatively, you may call 703–
235–0780 to register and to provide the
DHS Privacy Office with your name and
organizational affiliation, if any. The
Privacy Office will only use this
information for purposes of planning
this workshop and to contact you in the
event of any logistical changes. An
agenda and logistical information will
be posted on the workshop web page
shortly before the event. A written
transcript will be posted on the web
page following the event.
Special Assistance: Persons with
disabilities who require special
assistance should indicate this in their
E:\FR\FM\13NON1.SGM
13NON1
]]>Agencies
[Federal Register Volume 72, Number 218 (Tuesday, November 13, 2007)]
[Notices]
[Pages 63917-63918]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5616]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: December 3-5, 2007.
Time: December 3, 2007, 8 a.m. to 1 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols as well as related
data management activities. There will also be follow-ups on
Consideration of a Proposed Major Action under section III-A-1 of
the NIH Guidelines for Research Involving Recombinant DNA Molecules
and on a serious adverse event on a gene transfer trial using an AAV
vector.
Place: National Institutes of Health, Building 31, Floor 6C, 31
Center Drive, Conference Room 10, Bethesda, MD 20892.
Time: December 4, 2007, 8 a.m. to 3 p.m.
Agenda: Continued.
Place: National Institutes of Health, Building 31, Floor 6C, 31
Center Drive, Conference Room 10, Bethesda, MD 20892.
Time: December 5, 2007, 8 a.m. to 10:30 a.m.
Agenda: Continued.
Place: National Institutes of Health, Building 31, Floor 6C, 31
Center Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory Committee Coordinator,
Office of Biotechnology Activities, National Institutes of Health,
6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-
9838, lewallla@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
[[Page 63918]]
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www4.od.nih.gov/oba/, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to list these programs. Such a list would likely
require several additional pages. In addition, NIH could not be
certain that every Federal program would be included as many Federal
agencies, as well as private organizations, both national and
international, have elected to follow the NIH Guidelines. In lieu of
the individual program listing, NIH invites readers to direct
questions to the information address above about whether individual
programs listed in the Catalog of Federal Domestic Assistance are
affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: November 2, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5616 Filed 11-9-07; 8:45 am]
BILLING CODE 4140-01-M
